Will deduping (marking duplicates) with Picard before mapping affect my variant calling? Is it common practice to dedupe after mapping?
Reason why I ask is because my FastQC reports still have a lot of Kmer, overrepresented sequences, and bad GC content. I figured these can be corrected by removing PCR contamination. This is after trimming adapter and low quality (10) bases using BBDuk.